Fabry Disease Treatment Market (By Treatment: Enzyme Replacement Therapy (ERT), Chaperone Treatment, Substrate Reduction Therapy (SRT), Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
       1.1.1. Definition of Fabry Disease Treatment
       1.1.2. Market Segmentation
       1.1.3. List of Abbreviations
1.2. Summary
       1.2.1. Market Snapshot
       1.2.2. Fabry Disease Treatment Market By Treatment
                 1.2.2.1. Global Fabry Disease Treatment Market Revenue and Growth Rate Comparison By Treatment (2015-2026)
                 1.2.2.2. Global Fabry Disease Treatment Market Revenue Share By Treatment in 2017
                 1.2.2.3. Enzyme Replacement Therapy (ERT)
                 1.2.2.4. Chaperone Treatment
                 1.2.2.5. Substrate Reduction Therapy (SRT)
                 1.2.2.6. Others
       1.2.3. Fabry Disease Treatment Market by Geography
                 1.2.3.1. Global Fabry Disease Treatment Market Revenue and Growth Rate Comparison by Geography (2015-2026)
                 1.2.3.2. North America Fabry Disease Treatment Market Revenue and Growth Rate (2015-2026)
                 1.2.3.3. Europe Fabry Disease Treatment Market Revenue and Growth Rate (2015-2026)
                 1.2.3.4. Asia-Pacific Fabry Disease Treatment Market Revenue and Growth Rate (2015-2026)
                 1.2.3.5. Latin America Fabry Disease Treatment Market Revenue and Growth Rate (2015-2026)
                 1.2.3.6. Middle East and Africa (MEA) Fabry Disease Treatment Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
       2.4.1. Bargaining Power of Suppliers
       2.4.2. Bargaining Power of Buyers
       2.4.3. Threat of Substitute
       2.4.4. Threat of New Entrants
       2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
       2.6.1. Raw Material and Suppliers
       2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
       2.8.1. Player Positioning Analysis
       2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Fabry Disease Treatment Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Fabry Disease Treatment Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Fabry Disease Treatment Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Fabry Disease Treatment Major Manufacturers in 2017

CHAPTER 4. FABRY DISEASE TREATMENT MARKET BY TREATMENT

4.1. Global Fabry Disease Treatment Revenue By Treatment
4.2. Enzyme Replacement Therapy (ERT)
       4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Chaperone Treatment
       4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Substrate Reduction Therapy (SRT)
       4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Others
       4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. NORTH AMERICA FABRY DISEASE TREATMENT MARKET BY COUNTRY

5.1. North America Fabry Disease Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2. North America Fabry Disease Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
5.3. U.S.
       5.3.1. U.S. Fabry Disease Treatment Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       5.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
5.4. Canada
       5.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       5.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
5.5. Mexico
       5.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       5.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 6. EUROPE FABRY DISEASE TREATMENT MARKET BY COUNTRY

6.1. Europe Fabry Disease Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. Europe Fabry Disease Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. UK
       6.3.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       6.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.4. Germany
       6.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       6.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.5. France
       6.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       6.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.6. Spain
       6.6.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       6.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.7. Rest of Europe
       6.7.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       6.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 7. ASIA-PACIFIC FABRY DISEASE TREATMENT MARKET BY COUNTRY

7.1. Asia-Pacific Fabry Disease Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Asia-Pacific Fabry Disease Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. China
       7.3.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4. Japan
       7.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5. India
       7.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.6. Australia
       7.6.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       7.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.7. South Korea
       7.7.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       7.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.8. Rest of Asia-Pacific
       7.8.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       7.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 8. LATIN AMERICA FABRY DISEASE TREATMENT MARKET BY COUNTRY

8.1. Latin America Fabry Disease Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Latin America Fabry Disease Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. Brazil
       8.3.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Argentina
       8.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. Rest of Latin America
       8.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 9. MIDDLE EAST FABRY DISEASE TREATMENT MARKET BY COUNTRY

9.1. Middle East Fabry Disease Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Middle East Fabry Disease Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Saudi Arabia
       9.3.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. UAE
       9.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. Rest of Middle East
       9.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
       9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 10. AFRICA FABRY DISEASE TREATMENT MARKET BY COUNTRY

10.1. Africa Fabry Disease Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Africa Fabry Disease Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. South Africa
         10.3.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
         10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. Egypt
         10.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
         10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. Rest of Africa
         10.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
         10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 11. COMPANY PROFILE

11.1. Green Cross Pharma Pte Ltd.
         11.1.1. Company Snapshot
         11.1.2. Overview
         11.1.3. Financial Overview
         11.1.4. Product Portfolio
         11.1.5. Key Developments
         11.1.6. Strategies
11.2. Sanofi S.A.
         11.2.1. Company Snapshot
         11.2.2. Overview
         11.2.3. Financial Overview
         11.2.4. Product Portfolio
         11.2.5. Key Developments
         11.2.6. Strategies
11.3. Moderna Therapeutics Inc.
         11.3.1. Company Snapshot
         11.3.2. Overview
         11.3.3. Financial Overview
         11.3.4. Product Portfolio
         11.3.5. Key Developments
         11.3.6. Strategies
11.4. Shire Plc.
         11.4.1. Company Snapshot
         11.4.2. Overview
         11.4.3. Financial Overview
         11.4.4. Product Portfolio
         11.4.5. Key Developments
         11.4.6. Strategies
11.5. Greenovation Biotech Avrobio Inc.; GmbH
         11.5.1. Company Snapshot
         11.5.2. Overview
         11.5.3. Financial Overview
         11.5.4. Product Portfolio
         11.5.5. Key Developments
         11.5.6. Strategies
11.6. Amicus Therapeutics Inc.
         11.6.1. Company Snapshot
         11.6.2. Overview
         11.6.3. Financial Overview
         11.6.4. Product Portfolio
         11.6.5. Key Developments
         11.6.6. Strategies
11.7. Idorsia Pharmaceuticals Ltd.
         11.7.1. Company Snapshot
         11.7.2. Overview
         11.7.3. Financial Overview
         11.7.4. Product Portfolio
         11.7.5. Key Developments
         11.7.6. Strategies
11.8. ISU Abxis Co Ltd.
         11.8.1. Company Snapshot
         11.8.2. Overview
         11.8.3. Financial Overview
         11.8.4. Product Portfolio
         11.8.5. Key Developments
         11.8.6. Strategies
11.9. JCR Pharmaceuticals Co Ltd.
         11.9.1. Company Snapshot
         11.9.2. Overview
         11.9.3. Financial Overview
         11.9.4. Product Portfolio
         11.9.5. Key Developments
         11.9.6. Strategies
11.10. ProtalixBiotherapeutics Inc.
          11.10.1. Company Snapshot
          11.10.2. Overview
          11.10.3. Financial Overview
          11.10.4. Product Portfolio
          11.10.5. Key Developments
          11.10.6. Strategies
11.11. Others
          11.11.1. Company Snapshot
          11.11.2. Overview
          11.11.3. Financial Overview
          11.11.4. Product Portfolio
          11.11.5. Key Developments
          11.11.6. Strategies

CHAPTER 12. RESEARCH APPROACH

12.1. Research Methodology
         12.1.1. Initial Data Search
         12.1.2. Secondary Research
         12.1.3. Primary Research
12.2. Assumptions and Scope